Feedback / Questions
caxmotabart entudotin (IKS014) - Iksuda Therap
https://www.businesswire.com/news/home/20260105552386/en/Iksuda-to-Present-Preliminary-Analysis-of-Oesophageal-Cancer-Data-From-Phase-1-study-of-IKS014-at-ASCO-Gastrointestinal-Cancer-Symposium
Jan 6, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next